8-K/A
filed December 22, 2023, 6:59 PM ET
ticker AEMD
CIK 0000882291
leadership
confidence high
sentiment neutral
materiality 0.50
Aethlon Medical sets compensation for Frakes as Interim CEO ($500K salary) and Cipriani as COO ($390K)
AETHLON MEDICAL INC
- James Frakes appointed Interim CEO effective Nov 7, 2023; base salary raised from $360K to $500K while in role.
- Guy Cipriani appointed SVP & COO effective Nov 7, 2023; base salary set at $390K; resigned from Board.
- Frakes also remains CFO and joined Board; salary may revert upon hiring of permanent CEO.
- Cipriani resigns from Board per terms; reports to Interim CEO then to new CEO when appointed.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Guy F. Cipriani was appointed as Senior Vice President and Chief Operating Officer at AETHLON MEDICAL INC.
- Action
- appointed
- Role
- Senior Vice President and Chief Operating Officer
Exact text from the filing
Effective as of the Effective Date, Guy F. Cipriani, formerly Senior Vice President and Chief Business Officer of the Company, (i) was appointed as the Company’s Senior Vice President and Chief Operating Officer and (ii) resigned from the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Charles J. Fisher, Jr., M.D. departed as Chief Executive Officer at AETHLON MEDICAL INC.
- Action
- departed
- Role
- Chief Executive Officer
Exact text from the filing
(b) Departure of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Guy F. Cipriani resigned as Director at AETHLON MEDICAL INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
Resignation of Guy F. Cipriani as Director
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
James B. Frakes was appointed as Interim Chief Executive Officer at AETHLON MEDICAL INC.
- Action
- appointed
- Role
- Interim Chief Executive Officer
Exact text from the filing
Effective as of the Effective Date, Mr. Frakes, Chief Financial Officer of the Company, was appointed as (i) Interim Chief Executive Officer of the Company, replacing Dr. Fisher, and (ii) a member of the Board of Directors of the Company
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
James B. Frakes was appointed as Member of the Board of Directors at AETHLON MEDICAL INC.
- Action
- appointed
- Role
- Member of the Board of Directors
Exact text from the filing
Effective as of the Effective Date, Mr. Frakes, Chief Financial Officer of the Company, was appointed as (i) Interim Chief Executive Officer of the Company, replacing Dr. Fisher, and (ii) a member of the Board of Directors of the Company
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.